Clinical Trials Logo

Urinary Retention clinical trials

View clinical trials related to Urinary Retention.

Filter by:

NCT ID: NCT05428020 Completed - Clinical trials for Total Knee Arthroplasty

RCT Foley Catheter Study for Elective TJA

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

Urinary retention is a known complication following surgical procedures, with a theoretical increased risk in patients receiving neuraxial anesthesia due to a decreased ability to sense bladder distension. Urinary retention is associated with adverse events including bladder atony, increased post void residuals, and postoperative urinary tract infection. Treatment of urinary retention involves intermittent or indwelling urinary catheter placement, both of which are associated with an increased prevalence of postoperative urinary tract infection. There currently is no consensus whether the use of a urinary catheter in elective joint arthroplasty with neuraxial anesthesia decreases the risk of urinary retention. The prevalence of retention reported in the literature varies widely with reports anywhere from 0% to 75% in patients with early removal of a catheter or after procedures performed without a catheter. The goal of this study is to determine whether the routine use of an indwelling urinary catheter decreases the rate of postoperative urinary retention in patients undergoing elective joint arthroplasty.

NCT ID: NCT05314582 Completed - Hematuria Clinical Trials

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

Start date: March 10, 2022
Phase:
Study type: Observational [Patient Registry]

Patients who were using anticoagulant or antiaggregant medications for any reason and underwent transurethral resection of bladder tumor (TUR-BT) or transurethral resection of the prostate (TURP) or open prostatectomy (OP) due to BPH will be compared with those who were not using anticoagulant or antiplatelet medication. The rates of postoperative clot retention, presence of hematuria, reoperation due to hematuria, blood transfusion and re-admissions due to hematuria in the first postoperative month will be compared.

NCT ID: NCT05313984 Completed - Fecal Incontinence Clinical Trials

OptiLUTS Part C: The Development of a Symptom Assessment Tool in Sacral Neuromodulation.

OptiLUTS
Start date: March 1, 2018
Phase:
Study type: Observational

Sacral neuromodulation (SNM) is a two-staged 2nd-line therapy for therapy-resistant LUTS and fecal incontinence. Currently, the assessment of symptoms at baseline and after stage I is directed towards a discipline related evaluation. The OptiLUTS trial strives for a more holistic approach, taking all pelvic floor dysfunctions into account. A holistic assessment tool will be developed and SNM-care pathway will be set-up.

NCT ID: NCT05108506 Completed - Clinical trials for Urinary Retention Postoperative

Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy

Start date: December 5, 2022
Phase: N/A
Study type: Interventional

Patients who are undergoing non-urogynecologic, minimally invasive (laparoscopic, robotic) hysterectomy who are discharged the day of surgery will be randomized to a strict need to void versus no need to void prior to discharge. To determine if a strict versus liberal voiding trial following the aforementioned surgery in same day discharge patients increases rates of post-operative urinary retention, urinary tract infection (UTI), or re-presentation and if there is a difference in Post-Anesthesia Care Unit (PACU) time and costs.

NCT ID: NCT05064384 Completed - Fecal Incontinence Clinical Trials

Axonics SacRal NeuromodulaTIon System RegisTRY Study

ARTISTRY
Start date: November 30, 2020
Phase:
Study type: Observational [Patient Registry]

To assess the post-market clinical outcomes with use of the Axonics Sacral Neuromodulation System(s).

NCT ID: NCT04954443 Completed - Clinical trials for Pelvic Organ Prolapse

Urinary Retention After Removing Urinary Catheter at 24 Hour Versus 48 Hour in Patients With Vaginal Surgery

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Comparison incident of urinary retention in patients with vaginal surgery of pelvic organ prolapse, who removed urinary catheter at 24 hours versus 48 hours after surgery

NCT ID: NCT04859660 Completed - Clinical trials for Urinary Retention Postoperative

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

Start date: April 16, 2021
Phase: Phase 2
Study type: Interventional

The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.

NCT ID: NCT04783012 Completed - Clinical trials for Patient Satisfaction

Patient Removal of Catheters After Urogynecologic Surgery

CARES
Start date: February 15, 2021
Phase: N/A
Study type: Interventional

Management of postoperative urinary retention often requires the use of indwelling catheters. The purpose of this study is to see if patient removal of catheters at home is non-inferior to standard office removal.

NCT ID: NCT04715971 Completed - Aged Clinical Trials

Urinary Retention on an Acute Geriatric Hospitalisation Unit.

Start date: October 26, 2015
Phase:
Study type: Observational

Aim: The aim of this observational cohort study was to measure the prevalence of UR in patients aged ≥75 years on admission to an acute geriatric hospitalisation unit and to determine which at risk group would benefit from screening. Methods: Post-void residual volumes (PVR) were measured within 3 days of admission with an ultrasound bladder scan. Uni- and multivariable analysis were used to determine risk factors associated with PVR ≥150 and ≥300 millilitres.

NCT ID: NCT04557787 Completed - Retention, Urinary Clinical Trials

Investigation of Non-CE Marked Intermittent Catheters for Females

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Investigation of novel non-CE marked intermittent catheters. The study was a randomized, single blinded, cross-over investigation comparing two new catheters for females with a comparator catheter.